Article Excerpt: A new artificial intelligence (AI) study in The New England Journal of Medicine publication NEJM AI demonstrates how an AI chatbot called Therabot can significantly improve symptoms in just two months for those suffering from major depressive disorder (MDD), generalized anxiety disorder (GAD), and eating disorders.
“Generative artificial intelligence (Gen-AI) chatbots hold promise for building highly personalized, effective mental health treatments at scale, while also addressing user engagement and retention issues common among digital therapeutics,” wrote Dartmouth College’s Geisel School of Medicine senior author Nicholas Jacobson along with Michael Heinz, Daniel Mackin, Brianna Trudeau, Sukanya Bhattacharya, Yinzhou Wang, Haley Banta, Abi Jewett, Abigail Salzhauer, and Tess Griffin.
Full Article: https://tinyurl.com/2bbvpnwb
Article Source: Psychology Today